| |
|
|
| Name: |
Affinity Asset Advisors LLC |
| City: |
Bridgehampton |
| State: |
NY |
| Zip: |
11932 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
26 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
APGE |
Apogee Therapeutics, Inc. |
1 |
- |
$47.87 |
$39,345,000 |
592,093 |
6.86% |
24,339,000 |
55,000 |
1.233 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
2 |
- |
$0.00 |
$36,050,000 |
837,387 |
6.28% |
14,862,000 |
377,387 |
1.112 |
N/A |
|
|
MDGL |
Madrigal Pharmaceuticals Inc |
3 |
- |
$235.06 |
$30,710,000 |
115,000 |
5.35% |
7,572,000 |
15,000 |
0.583 |
Diagnostic Substances |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
4 |
- |
$50.54 |
$22,001,000 |
470,000 |
3.83% |
6,093,000 |
22,905 |
0.64 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
5 |
- |
$3.84 |
$21,533,000 |
3,375,000 |
3.75% |
11,548,000 |
1,824,592 |
1.95 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
6 |
- |
$38.10 |
$21,405,000 |
510,000 |
3.73% |
5,541,000 |
110,000 |
0.811 |
Diagnostic Substances |
|
|
INZY |
Inozyme Pharma, Inc. |
9 |
- |
$0.00 |
$20,242,000 |
2,642,519 |
3.53% |
12,208,000 |
756,717 |
4.279 |
N/A |
|
|
KURA |
Kura Oncology Inc |
11 |
- |
$22.55 |
$15,581,000 |
730,492 |
2.71% |
12,827,000 |
538,957 |
0.872 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
13 |
- |
$0.00 |
$13,159,000 |
817,833 |
2.29% |
1,950,000 |
254,009 |
1.014 |
N/A |
|
|
NRIX |
Nurix Therapeutics, Inc. |
16 |
- |
$0.00 |
$11,911,000 |
810,253 |
2.08% |
4,789,000 |
120,141 |
1.722 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
19 |
- |
$76.79 |
$11,153,000 |
139,758 |
1.94% |
7,173,000 |
89,758 |
0.295 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
20 |
- |
$43.60 |
$9,699,000 |
165,000 |
1.69% |
5,209,000 |
90,000 |
0.144 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
21 |
- |
$0.00 |
$9,385,000 |
830,546 |
1.64% |
3,051,000 |
34,817 |
0.95 |
N/A |
|
|
CMPS |
Compass Pathways Plc |
23 |
- |
$0.00 |
$8,552,000 |
1,027,868 |
1.49% |
3,739,000 |
477,868 |
2.953 |
N/A |
|
|
NARI |
Inari Medical, Inc. |
24 |
- |
$0.00 |
$8,397,000 |
175,000 |
1.46% |
7,099,000 |
155,000 |
0.339 |
N/A |
|
|
MORF |
Morphic Holding, Inc. |
27 |
- |
$29.26 |
$7,920,000 |
225,000 |
1.38% |
6,688,000 |
182,330 |
0.452 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
28 |
- |
$0.00 |
$6,769,000 |
286,200 |
1.18% |
5,373,000 |
161,200 |
0.351 |
N/A |
|
|
PCVX |
Vaxcyte, Inc. |
34 |
- |
$0.00 |
$5,465,000 |
80,000 |
0.95% |
3,895,000 |
55,000 |
0.074 |
N/A |
|
|
FULC |
Fulcrum Therapeutics, Inc. |
36 |
- |
$0.00 |
$5,195,000 |
550,339 |
0.91% |
4,351,000 |
425,339 |
0.873 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
38 |
- |
$169.25 |
$4,759,000 |
26,746 |
0.83% |
1,657,000 |
1,746 |
0.107 |
N/A |
|
|
MIRM |
Mirum Pharmaceuticals, Inc. |
44 |
- |
$0.00 |
$4,019,000 |
160,000 |
0.7% |
2,543,000 |
110,000 |
0.298 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
45 |
- |
$0.00 |
$3,767,000 |
75,000 |
0.66% |
-520,000 |
4,012 |
0.125 |
N/A |
|
|
IMTX |
Immatics N.V |
46 |
- |
$10.34 |
$3,679,000 |
350,000 |
0.64% |
1,573,000 |
150,000 |
0.556 |
N/A |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
50 |
- |
$5.93 |
$2,952,000 |
450,000 |
0.51% |
2,524,000 |
384,000 |
0.694 |
N/A |
|
|
TVTX |
Travere Therapeutics, Inc |
63 |
- |
$6.56 |
$964,000 |
125,000 |
0.17% |
964,000 |
125,000 |
0.143 |
N/A |
|
|
AVRO |
Averion International Corp |
64 |
- |
$1.40 |
$896,000 |
700,000 |
0.16% |
216,000 |
200,000 |
1.92 |
Biotechnology |
|
